Journal of Neoplasms

Aims and Scope

Journal of Neoplasms (JN) is a peer-reviewed, open access journal that publishes high-quality, scholarly articles in the fields of neoplasms and oncology, with a focus on the biology, development, and treatment of cancer. 

Neoplasms are abnormal, uncontrolled growths of tissue that have the potential to spread and cause serious health issues. They can occur in any tissue or organ and can range from benign, non-cancerous tumors to invasive, life-threatening tumors. Neoplastic disorders are among the most pressing global health concerns, with thousands of new cases being diagnosed each year. 

Neoplasms can arise due to environmental factors, such as exposure to toxins, radiation, and carcinogens; genetic predisposition; lifestyle and dietary factors; and infections. Journal of Neoplasms focuses on both experimental and clinical studies related to neoplasms, such as cancer and tumor biology, carcinogenesis, and metastasis. The journal provides a platform for researchers, clinicians, and medical professionals to share the latest research advancements and results including tumors, carcinomas, lymphomas, and sarcomas, as well as their causative agents, treatments, and preventative measures. It also covers advances in immunotherapy, genetics, and genomics of neoplasms, novel biomarkers, and advances in imaging in neoplasm diagnosis and prognosis.

We seek to provide comprehensive data, analyses, and evidence-based research including tumorigenesis and metastasis, immunology and immunotherapy, stem cell transplantation, radiotherapy and oncological drug therapy, artificial intelligence and big data in neoplasms, and much more. We strive to facilitate an understanding of the various factors involved in the diagnosis, prognosis, and treatment of this widespread and often difficult condition. By sharing the most cutting-edge developments in the field, we strive to ultimately improve the quality of life for those living with neoplasms. 

JN is pleased to publish research that covers topics related to neoplasms, ranging from epidemiology to pathology, carcinogenesis, etiopathogenesis, and clinical management. The diagnosis of neoplasms involves analyzing medical history, physical examination, laboratory tests, imaging studies, and biopsies. Treatment for neoplasms can include surgery, chemotherapy, radiation therapy, and sometimes a combination of therapies. Neoplasms are one of the most complex diseases due to their indefinite range of severity and type, which makes research and medical advancements a challenging and ongoing process. 
 

We strive to provide a platform for researchers to share quality research findings and to help improve the care of patients with neoplasms. The journal welcomes submissions from researchers around the world who are working to advance the diagnostic, therapeutic, and prognostic understanding of neoplasms. 
 

The following topics can be covered in the Journal of Neoplasms

• Lymphoma
• Melanoma
• Leukemia
• Skin Cancer
• Breast Cancer
• Basal cell carcinoma
• Pancreatic Cancer
• Prostate Cancer
• cervical cancer
• Esophageal cancer
• Testicular Cancer
• Thyroid Cancer
• Ovarian Cancer
• Stomach Cancer
• Throat cancer
• Bladder cancer
• Colorectal Cancer
• Neurofibromatosis
• Oral Cancer
• Acute Myeloid Leukemia
• Malignant Neoplasm
• Acute lymphocytic leukemia
• Hairy Cell Leukemia
• Non-Small Cell Lung Cancer
• Gastrointestinal Cancer
• Parotid Gland Cancer
• Primary Peritoneal Cancer
• genitourinary cancer
• Gastrointestinal Stromal Tumors
• Hematological Malignancies
• Cancer
• Tumors
• Oncology
• Cancer treatment
• Cancer research
• Cancer diagnosis
• Cancer prevention
• Cancer screening
• Cancer genetics
• Cancer therapy
• Cancer immunotherapy
• Chemotherapy
• Radiation therapy
• Targeted therapy
• Precision medicine
• Biomarkers
• Personalized medicine
• Clinical trials
• Cancer epidemiology
• Cancer biology
• Cancer immunology
• Cancer pathology
• Cancer metastasis
• Cancer staging
• Cancer prognosis
• Cancer survivorship
• Cancer recurrence
• Cancer palliative care
• Brain tumors
• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer
• Pancreatic cancer